Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3739
Source ID: NCT00057304
Associated Drug: Ro 205-2349
Title: Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes
Interventions: DRUG: RO 205-2349
Outcome Measures:
Sponsor/Collaborators: Sponsor: Hoffmann-La Roche
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 190
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2003-06
Completion Date: 2004-03
Results First Posted:
Last Update Posted: 2023-04-28
Locations: Hollywood, Florida, 33021, United States|Durham, North Carolina, 27710, United States|Morrisville, North Carolina, 27560, United States|Portland, Oregon, 97219, United States|Portland, Oregon, 97239, United States|Camp Hill, Pennsylvania, 17011, United States|Greer, South Carolina, 29651, United States|Memphis, Tennessee, 38119, United States|Memphis, Tennessee, 38163, United States|Dallas, Texas, 75230, United States|Houston, Texas, 77030, United States|Midland, Texas, 79705, United States|Lebanon, Virginia, 24266, United States|Virginia Beach, Virginia, 23451, United States|Pleven, 5800, Bulgaria|Plovdiv, 4002, Bulgaria|Sofia, 1233, Bulgaria|Sofia, 1431, Bulgaria|Sofia, 1606, Bulgaria|Tallinn, 10138, Estonia|Tartu, 50406, Estonia|Tartu, 50708, Estonia|Voru, 65609, Estonia|Chihuahua, Chih., Mexico|Guadalajara, JAL., 44340, Mexico|Guadalajara, 44349, Mexico|Merida, 97000, Mexico|Mexico City, 06700, Mexico|Monterrey, 64320, Mexico|Monterrey, 64410, Mexico|Monterrey, 64460, Mexico|Pachuca, Hidalgo, 42039, Mexico|Panama, Panama|Ponce, 00732-7994, Puerto Rico|Arad, 2900, Romania|Brasov, 500326, Romania|Bucuresti, 020475, Romania|Bucuresti, 7000, Romania|Craiova, 1100, Romania|Galati, 6200, Romania|Ploiesti, 2000, Romania|Targoviste, 0200, Romania|Tirgu-mures, 4300, Romania|Meyrin, 1217, Switzerland|Bracknell, RG12 1HX, United Kingdom|Nottingham, NG2 3HF, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00057304

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress